Postoperative dexamethasone does not reduce risk of adverse events following major non-cardiac surgery
1. This phase III drug trial showed that dexamethasone does not significantly reduce risk of adverse events and death following ...
1. This phase III drug trial showed that dexamethasone does not significantly reduce risk of adverse events and death following ...
1. Reduced-dose glucocorticoid plus rituximab regimen was non-inferior compared to high-dose glucocorticoid plus rituximab regimen for induction of disease remission ...
1. In this retrospective cohort study, the risk of an atypical fracture increased with longer duration of bisphosphonate use while ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.